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Introduction
Neutrophils are the first line of immune defense (Lekstrom-
Himes and Gallin, 2000; Nathan, 2006), and they combat patho-
gens by phagocytosis, degranulation, and the release of neutrophil 
extracellular traps (NETs; Brinkmann et al., 2004; Nauseef, 
2007; Papayannopoulos and Zychlinsky, 2009). NETs are com-
posed of decondensed chromatin and antimicrobial factors, in-
cluding neutrophil elastase (NE) and myeloperoxidase (MPO; 
Brinkmann et al., 2004; Urban et al., 2009), and capture and kill 
bacteria, fungi, and parasites (Urban et al., 2006; Guimarães-
Costa et al., 2009; Ramos-Kichik et al. 2009). NETs are impli-
cated in immune defense, sepsis, and autoimmunity (Clark   
et al., 2007; Kessenbrock et al., 2009; Papayannopoulos and 
Zychlinsky, 2009; Hakkim et al., 2010). Mast cells, eosinophils, 
and plant cells also release DNA, which suggests that this may 
be a common strategy in immunity (von Köckritz-Blickwede   
et al., 2008; Yousefi et al., 2008; Wen et al., 2009).
NE and MPO are stored in azurophilic granules of naive 
neutrophils (Borregaard and Cowland, 1997; Lominadze et al., 
2005). NE is a neutrophil-specific serine protease that degrades 
virulence factors and kills bacteria (Lehrer and Ganz, 1990;   
Belaaouaj et al., 2000; Weinrauch et al., 2002). MPO catalyzes the 
oxidation of halides by hydrogen peroxide (Hazen et al., 1996; 
Eiserich et al., 1998; Nauseef, 2007). NE and MPO knockout mice 
are susceptible to bacterial and fungal infections (Belaaouaj   
et al., 1998; Aratani et al., 1999; Tkalcevic et al., 2000; Gaut   
et al., 2001; Belaaouaj, 2002). Interestingly, histones are the most 
abundant NET component and are potent antimicrobials (Hirsch, 
1958; Kawasaki and Iwamuro, 2008; Urban et al., 2009).
Isolated human neutrophils release NETs 2–4 h after stim-
ulation with microbes or activators of PKC such as PMA (Fuchs 
et al., 2007), but respond much faster when activated by platelet 
cells stimulated with LPS, a process thought to be relevant during 
sepsis (Clark et al., 2007).
NETs form via a novel form of cell death (Fuchs et al., 
2007) that requires the production of reactive oxygen spe-
cies (ROS). Neutrophils from chronic granulomatous disease   
patients  with  mutations  in  the  NADPH  oxidase  that  disrupt 
ROS production (Clark and Klebanoff, 1978) fail to form NETs 
(Fuchs et al., 2007; Bianchi et al., 2009). In neutrophils from 
healthy donors, ROS production is followed by the disassembly 
of the nuclear envelope. Chromatin decondenses in the cyto-
plasm and binds to granular and cytoplasmic antimicrobial 
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Figure 1.  NE cleaves histones and promotes nuclear decondensation in vitro. (A) Nuclei isolated from neutrophils were incubated in buffer or in neutrophil-
derived LSS lysates for 120 min at 37°C and labeled with Sytox green. Bar, 10 µm. (B) Neutrophil extracts are sufficient to decondense nuclei from other 
cell types. Nuclear decondensation of LSS extracts from HL-60 cells differentiated with RA, HeLa cells, PBMCs, and neutrophils were tested with nuclei 679 Neutrophil elastase in extracellular trap formation • Papayannopoulos et al.
proteins before NET release. Chromatin decondensation and 
the association with antimicrobial proteins are two essential 
steps during NET formation. The molecular mechanism linking 
ROS production to chromatin decondensation and binding to 
antimicrobial proteins is unknown.
Here we show that NE is essential to initiate NET for-
mation and that it synergizes with MPO to drive chromatin 
decondensation. Our findings reveal a novel mechanism to 
drive massive chromatin decondensation, and provide evidence 
for a novel pathway that allows granular proteins to leak into 
the cytoplasm.
Results
Neutrophil extracts promote  
chromatin decondensation
To identify factors involved in NET formation, we developed a 
cell-free nuclear decondensation assay using intact nuclei and 
cytoplasmic extracts from neutrophils and other control cells. 
Only the neutrophil-derived low-speed supernatant (LSS), con-
taining cytoplasm and granules, decondensed nuclei from neu-
trophils, peripheral blood mononuclear cells (PBMCs), human 
leukemia-60 (HL-60), and HeLa cells (Fig. 1, A and B), which 
indicates that neutrophil LSS contains specific factors that de-
condense nuclei. Further separation of the LSS into cytoplasmic 
(high-speed supernatant [HSS]) and membrane/granule (high-
speed pellet [HSP]) fractions showed that the decondensation 
activity partitioned with the HSP (Fig. 1 C). Neutrophils con-
tain azurophilic, specific, and gelatinase granules (Borregaard 
and Cowland, 1997). The decondensation activity fractionated 
with the azurophilic granules (Fig. 1 C, fraction 3; Kjeldsen et al., 
1994), which suggests that granular factors are not only com-
ponents of NETs but are also involved in their formation.
NE is necessary and sufficient for 
chromatin decondensation
NE and MPO are two of the primary enzymes stored in azuro-
philic granules and are found in abundance in NETs. Un-
like MPO, only NE sedimented exclusively to the azurophilic 
fraction (Fig. 1 D, lane 3; Lominadze et al., 2005). We tested 
whether the activity of NE and MPO is required for nuclear   
decondensation.  Chromatin  decondensation  was  blocked  by 
two NE inhibitors, GW311616A (NEi) and serum leukocyte 
protease inhibitor (SLPI; Macdonald et al., 2001), but not by the 
MPO inhibitor 4-aminobenzoic acid hydrazide (ABAH; Fig. 1 C;   
Kettle et al., 1997).
Azurophilic granules store two additional NE-related pro-
teases, proteinase 3 (PR3) and cathepsin G (CG). Using protease-
specific chromogenic peptides and histones as substrates, we 
show that NEi inhibits NE and PR3, but not CG (Fig. S1). SLPI 
is known to inhibit NE and CG but not PR3 (Rao et al., 1991). 
Considering the specificity of these inhibitors, these results in-
dicate that PR3 is not sufficient to drive decondensation in vitro. 
In addition, CG inhibitor I (CGi), a CG-specific inhibitor, did 
not inhibit nuclear decondensation. Collectively, these data sug-
gest that among these serine proteases, only NE is required for 
the decondensation of the nucleus.
NE degrades histones to promote  
nuclear decondensation
Because histones pack DNA, we examined whether histones 
H3 and H4 are degraded in nuclei treated with LSS. To dis-
tinguish between histone degradation and histone release, we 
separated the soluble unbound proteins (SF) from the nuclear 
fraction (NF) by filtration. Interestingly, H4, but not H3, was 
degraded in an NE-dependent manner (Fig. 1 E). We also mon-
itored the kinetics of nuclear localization of NE and MPO in   
relation to histone degradation and nuclear decondensation. Both 
NE and MPO were detected in the nuclear fraction within the 
first 30 min. Notably, H1 was degraded early but decondensation 
coincided with H4 degradation at 150 min (Fig. 1 F), which 
suggests that nuclear decondensation is driven primarily by the 
degradation of core histones (Fig. 1 G). However, H1 may have 
to be degraded first to allow for the subsequent degradation of 
core histones.
Moreover, purified NE and PR3, but not CG, promoted 
nuclear decondensation in vitro (Fig. 1 H, Fig. S1 F, and not de-
picted). NE degraded H4 processively, whereas the other his-
tones were only partially degraded (Fig. 1 I). Histone degradation 
was detectable by 30 min and coincided with nuclear deconden-
sation (Fig. 1, H and I). As a control, we showed that NE com-
pletely  degraded  soluble  histones  purified  from  neutrophils 
(Fig. 1 I), which indicates that the pattern of histone degra-
dation depends on chromatin structure and not on the intrinsic 
isolated from neutrophils (Neut). The nuclear area was quantified using ImageJ image processing software. Circles denote the median area and the bars 
indicate the range of the nuclear area values, calculated from the standard deviation of each dataset. (C) Decondensation activity is stored in azurophilic 
granules. Decondensation of nuclei treated with buffer, neutrophil LSS, neutrophil HSS, HSP, and the granular subfractions of gelatinase (1), specific (2), 
and azurophilic (3) granules were purified over a discontinuous Percoll gradient. Nuclei were also incubated with LSS or HSP in the presence or absence 
of NEi, SLPI, CGi, or ABAH. Inhibitors were used at the indicated concentrations. (D) The purity of gelatinase (1), specific (2), and azurophilic (3) granule 
fractions was tested by SDS-PAGE immunoblot analysis using antibodies against gelatinase, lactoferrin, MPO, and NE. NE fractionates exclusively with 
azurophilic granules (3). (E) NEi inhibits the degradation of nuclear H4 in vitro. After 120 min at 37°C, decondensation reactions were passed over a 
0.65-µm filter to separate the nuclei from the extract. The total reaction (T), flowthrough (SF), or nuclear (NF) fractions were analyzed by immunoblotting. 
Top, nuclei in buffer; middle, nuclei in LSS; bottom, nuclei incubated with LSS and 5 µM NEi. (F) NE and MPO translocate to nuclei in vitro. LSS (L), nuclei 
alone (N), or LSS + nuclei (L+N), were incubated for the indicated time and separated over filters as in E. The levels of H1, H4, NE, and MPO in the nuclear 
fraction at different time points were analyzed by immunoblotting. (G) A plot of the corresponding nuclear decondensation, measured as in A, for the 
experiment in F. (H) Purified NE is sufficient to decondense nuclei in vitro. Nuclei were incubated with buffer (B) or 1 µM purified NE (NE) in the absence 
of MPO (no MPO, open circles) for the indicated duration (0–240 min). In parallel, 1 µM MPO was added to the same samples (+MPO, closed circles). 
Decondensation was measured by quantifying the nuclear area and was significantly enhanced in the presence of both NE and MPO (closed circles).   
(I) Purified NE cleaves nuclear histones in vitro. The samples from H along with NE incubated with purified neutrophil histones were resolved by SDS-PAGE 
and analyzed by immunoblotting. H4 was processively degraded but H2A, H2B, and H3 were only partially degraded by NE. Soluble purified histones 
were completely degraded. Notably, the addition of 1 µM MPO had no effect on histone degradation by NE (third column). ***, P < 0.0001.
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To investigate whether high concentrations of NE de-
creased histone degradation, we incubated nuclei with increasing 
NE concentrations and separated the nuclear (NF) and soluble 
(SF) fractions over filters (Fig. 2 E). H4 was degraded under 
optimal, but not autoinhibitory, concentrations of NE. Notably, 
NE activity is not required for NE binding to nuclei, as it parti-
tioned with nuclei in the presence of NEi. The lower levels of 
NE in the NF fraction in the absence of NEi suggest that NE 
degrades itself in the nucleus (Fig. 2 E, left, asterisks).
We asked whether NE and MPO interact inside the nu-
cleus by incubating nuclei with NE and low concentrations of 
MPO. MPO nuclear localization was independent of NE activ-
ity, as significant amounts of MPO were found in the nuclear 
fraction in the presence of NEi (Fig. 2 E, right). Moreover, we 
observed NE-dependent MPO degradation in the nuclear, but 
not in the soluble fraction, which indicates that these proteins 
come into close proximity in the nucleus.
NE activity is required for NET formation 
in neutrophils
To investigate whether NE activity is required for NET forma-
tion, we pretreated neutrophils isolated from healthy donors 
with NEi or CGi, and induced NET formation with PMA in the 
presence of Sytox, a cell-impermeable DNA dye. Untreated 
neutrophils and cells treated with CGi formed NETs efficiently 
2–4 h after activation. Notably, NEi-treated neutrophils failed to 
make NETs, and appeared necrotic as determined by the Sytox-
positive condensed nuclei (Fig. 3 A). To quantitate NET formation, 
we measured the DNA area of each Sytox-positive neutrophil 
and plotted the percentage of Sytox-positive cells against their 
corresponding nuclear area (Fig. 3 B). Our quantitation con-
firmed that neutrophil death is dramatically reduced in the 
presence of NEi (11.2% vs. 63.7%), whereas the low nuclear 
areas of the dead cells indicate that cells did not make NETs 
but were necrotic.
Candida albicans is a potent physiological activator of 
NET formation in isolated primary neutrophils. Neutrophils 
treated with NEi failed to make NETs efficiently when ex-
posed to C. albicans (Fig. 3 C). The number of neutrophils 
that died without making NETs increased dramatically and 
was comparable to neutrophils treated with NEi and stimu-
lated with PMA (Fig. 3 D). Interestingly, C. albicans induced 
NET formation with lower efficiency than PMA (Fig. 3 D), 
which indicates that when presented with microbes, neutro-
phils may respond in different ways, with some neutrophils 
consuming NE and MPO through phagocytosis or degranula-
tion while others form NETs.
As controls, we show that NEi was not cytotoxic (Fig. 3 E)   
and did not inhibit ROS production, which was potently blocked 
by the NADPH oxidase inhibitor diphenyleneiodonium (DPI; 
Fig. 3 F; Cross and Jones, 1986).
NE cleaves histones during NET formation
Because PMA is a more potent inducer of NETs than C. albi-
cans and other microbes, we used it to examine whether his-
tones are degraded in an NE-dependent manner during NET 
formation. Consistent with our in vitro data, H2B and H4 were 
susceptibility of histones to this protease. Similarly, purified 
PR3 cleaved nuclear histones in vitro (Fig. S1 E). In con-
trast, and consistent with our previous observations, nuclear 
and purified histones were poor substrates for CG (unpub-
lished data).
To examine whether the degradation of histones is caus-
ing chromatin decondensation, we preincubated permeabilized 
nuclei with antihistone or a control antibody against CD63, a 
transmembrane granular protein. Nuclear decondensation was 
reduced by 50% in nuclei incubated with antibodies against H4, 
and to a lesser extent with antibodies against other core histones 
(Fig. S2 A), but not by the control antibody. Accordingly, H4 
degradation was reduced in nuclei treated with antihistone anti-
bodies (Fig. S2 B).
Interestingly, in a fractionation experiment, we purified 
H1 as an inhibitor of NET formation (unpublished data). H1 
promotes the condensed, closed state of chromatin, which re-
stricts its accessibility (Roche et al., 1985; Bustin et al., 2005; 
Woodcock et al., 2006). Nuclei pretreated or coincubated with 
H1 were resistant to decondensation and histone degradation   
by LSS and HSP (Fig. S2, C–E). Moreover, MPO failed to par-
tition with the NF in nuclei pretreated with H1, which indicates 
that chromatin is the primary binding site of MPO in vitro   
(Fig. S2 D). Therefore, NE and MPO require access to the core 
histones to degrade them and induce decondensation.
NE and MPO synergize to promote  
nuclear decondensation
Because MPO localizes to NETs and binds to nuclei in vitro 
(Fig. 1 F), we tested whether MPO promotes nuclear deconden-
sation (Brinkmann et al., 2004). At 1 µM, MPO alone had little 
effect, but it dramatically enhanced chromatin decondensation 
in the presence of NE (Fig. 1 H). Interestingly, MPO did not   
affect histone degradation, which suggests that it does not up-
regulate NE activity (Fig. 1 I). MPO promoted nuclear de-
condensation in a dose-dependent manner that did not require 
its substrate H2O2 and was not inhibited by ABAH (Fig. 2,   
A and B). Furthermore, horseradish peroxidase, used as a control 
for enzymatic activity, did not promote chromatin deconden-
sation (unpublished data). We concluded that MPO enhances 
NET formation independent of its enzymatic activity.
To better understand the synergy between NE and MPO, 
we measured its effect on nuclear decondensation driven by NE. 
Increasing amounts of MPO enhanced NE-mediated nuclear 
decondensation (Fig. 2 C). Surprisingly, high concentrations   
of NE inhibited nuclear decondensation (Fig. 2 D). This auto-
inhibition could be caused by NE autodegradation. Alternatively,   
at high concentrations, NE could inhibit histone degradation.   
Accordingly, DNA has been shown to inhibit NE (Belorgey and 
Bieth, 1995). We confirmed the inhibitory effect of DNA on NE 
and CG, and found that it was reversed by the addition of NaCl 
(Fig. S3, A and B). Intact nuclei also inhibited NE activity, but 
this effect was not reversed by the addition of NaCl. Therefore, 
after histone cleavage, NE activity may be down-regulated by 
binding  to  DNA. Autoinhibition  was  not  observed  for  PR3, 
which completely dissolved the nuclei at high concentrations 
(Fig. S1, E and F).681 Neutrophil elastase in extracellular trap formation • Papayannopoulos et al.
Figure 2.  NE and MPO synergize. (A) Effect of MPO titration on nuclear decondensation in vitro. Nuclei were incubated with the indicated concentra-
tions of MPO for 30 (open circles), 60 (gray circles), or 120 min (closed circles). Decondensation was concentration- but not time-dependent. (B) MPO 
promotes decondensation independent of its enzymatic activity. Nuclei were treated with 5 µM MPO alone or MPO in the presence of 100 µM ABAH (an 
MPO inhibitor), 100 µM H2O2 (MPO substrate), or both. (C) Nuclear decondensation was driven by titration of NE at different concentrations of MPO.   
MPO increases NE-mediated decondensation. (D) The effect of NE titration on nuclear decondensation. Nuclei were incubated with the indicated concen-
trations of NE in the absence (black line) or presence (red line) of 10 µM NEi for 120 min before measuring nuclear decondensation. (E) NE-mediated 
degradation of histones is dose-dependent during nuclear decondensation. Western immunoblot analysis of MPO, H4, and NE was performed. Nuclei 
mixed with increasing concentrations of NE and 0.3 µM MPO for 120 min were separated into nuclear (NF, left) and soluble (SF, right) fractions. Reactions 
were performed in the absence or presence of NEi. The samples where nuclei decondensed are indicated by positive signs below the NF blot. Asterisks 
mark the levels of NE bound to nuclei, in the presence or absence of NEi, at the highest concentration of NE. ***, P < 0.0001.
partially degraded during NET formation, whereas H3 shifted 
to a higher molecular weight species (Fig. 4 A). The presence of 
NEi inhibited the degradation of H4 and significantly reduced 
the degradation of H2B. NEi also prevented the formation of 
an H2A degradation product, which was observed in both naive 
and activated cells in the absence of the inhibitor. The higher JCB • VOLUME 191 • NUMBER 3 • 2010   682
Figure 3.  NE is required for NET formation. (A) NEi but not CGi, a CG inhibitor, blocks NET formation. Purified human neutrophils, untreated or pretreated 
with NEi or CGi, were either activated with PMA for 4 h or left unactivated (naive) in the presence of 10% FCS. Shown are fluorescence images of cells in   
the presence of the cell-impermeable DNA dye Sytox green (left), and phase contrast images (right). Bar, 50 µm. (B) Quantitation of chromatin decondensation 683 Neutrophil elastase in extracellular trap formation • Papayannopoulos et al.
Histone degradation was detected before cell death and 
peaked during NET formation (Fig. 4 B). NET release and 
neutrophil death occurred simultaneously between 2 h and 3 h 
after stimulation, as indicated by the large DNA area of all 
Sytox-positive neutrophils, which was blocked in the presence 
molecular weight H3 species in both activated and naive neu-
trophils were independent of NE activity and may represent 
other posttranslational modifications. Histones were degraded 
2–4 h after stimulation, coinciding with the peak of NET re-
lease (Fig. 4 B).
in samples from A. A plot of the distribution of Sytox-positive neutrophils with respect to the chromatin area is shown. Naive cells at 4 h (orange), cells 
stimulated with PMA alone (black), or stimulated with PMA in the presence of NEi (yellow) or CGi (purple) were quantified. The overall percentage of 
Sytox-positive cells for each sample is shown in parentheses. Representative data out of six independent experiments are shown. (C) NEi blocks NET forma-
tion stimulated by C. albicans. Neutrophils were untreated or pretreated with 10 µM NEi in 10% human serum, and incubated with C. albicans for 3 h at 
MOI = 10 in the presence of Sytox. Extracellular DNA was visualized by Sytox fluorescence. PMA-stimulated and PMA + NEi control neutrophils from the 
same donor are shown as well. NET formation by C. albicans is less efficient than with PMA, and is blocked by NEi. (D) Quantitation of C. The distribution 
of Sytox-positive cells against their DNA area is shown. The right inset depicts the percentage of NETs as the number of cells whose DNA area exceeds 
400 µm
2. Representative data out of three independent experiments are shown. (E) NEi is not cytotoxic. Release of LDH, a cytoplasmic protein, is used to 
monitor cell lysis. LDH levels in the medium of naive neutrophils after a 5-h incubation in the presence of increasing levels of NEi (0, 1, 10, and 30 µM). 
LDH levels are normalized to the total LDH content of an equivalent number of neutrophils lysed with detergent (total). (F) 5 µM NEi and 5 µM CGi have no 
effect on the production of ROS in response to PMA. Neutrophils were either untreated or pretreated with NEi, CGi, or the NADPH oxidase inhibitor DPI as 
a control. Subsequently, cells were stimulated with PMA, and ROS were detected by monitoring luminol chemiluminescence in the presence of horseradish 
peroxidase. Mean values and the standard deviation from triplicate samples for each condition are presented (error bars). ***, P < 0.0001.
 
Figure 4.  NE partially degrades core histones during NET formation. (A) Histone cleavage during NET formation is inhibited by NEi. Western immuno-
blotting against histones in lysates of naive (N) and PMA-activated neutrophils (PMA) in the presence (+NEi) or in the absence of NEi (untreated).   
(B and C) Quantitation of chromatin decondensation for the samples shown in A. (B) Untreated neutrophils. (C) Neutrophils treated with NEi. Shown are 
naive neutrophils at 0 h (gray) or 4 h (black), activated with PMA for 1 (yellow), 2 (orange), 3 (red), or 4 h (blue). (D) NE is not significantly externalized 
before NET formation. The time course of the release of NE into the medium by neutrophils activated with PMA measured by ELISA is shown. MNase was 
added to solubilize NE bound to DNA. Samples were normalized to NE levels from plated naive neutrophils lysed with 0.1% Triton X-100 (Total).JCB • VOLUME 191 • NUMBER 3 • 2010   684
Figure 5.  NE, PR3, and MPO localization during NET formation. (A–C) Naive and PMA-activated neutrophils in the presence or absence of NEi, fixed at 
the indicated time points and immunolabeled for NE (red) and PR3 (green; A), or NE (red) and MPO (green; B and C). DNA was stained with DRAQ5 
(blue). (A) NE, and to a lesser extent PR3, translocate to the nucleus within 60 min after stimulation. (B) MPO associates with DNA before cell lysis but   
later than NE. (C) NEi prevents NE and MPO translocation to the nucleus, and chromatin decondensation. Bar, 5 µm. (D) NE is released from the granules 685 Neutrophil elastase in extracellular trap formation • Papayannopoulos et al.
dose of Klebsiella pneumoniae, a Gram-negative bacterium that 
causes pneumonia. Neutrophils were massively recruited to the 
lungs 48 h after infection in both groups of animals, confirming 
that the loss of NE does not interfere with neutrophil recruit-
ment (Hirche et al., 2004). The lungs of WT mice contained de-
condensed web-like structures that stain with antibodies against 
MPO and an H2A-H2B-DNA complex (Fig. 6 A, i; Brinkmann 
et al., 2004). NETs have also been observed in a mouse pneumo-
coccal pneumonia model (Beiter et al., 2006). In contrast, in the 
lungs of infected NE knockout animals, neutrophils exhibited 
condensed nuclei, and MPO did not colocalize with the DNA 
marker but remained granular (Fig. 6 A, ii).
We also analyzed these sections by scanning electron   
microscopy. NETs entrapping bacteria were present in abun-
dance in the lungs of WT animals (Fig. 6 B, i and ii). In contrast, 
the lungs of NE knockout mice were devoid of structures re-
sembling NETs on lung tissues and bacterial surfaces (Fig. 6 B,   
iii and iv). The absence of NETs in NE single knockout animals 
indicates that the extracellular DNA detected in the lungs of WT 
mice does not originate from bacterial biofilm, as such struc-
tures would be present in both groups of mice. Furthermore, 
these results suggest that PR3 cannot complement the loss of 
NE in NET formation.
In  addition,  we  examined  nuclear  decondensation  by 
extracts derived from mouse peritoneal neutrophils. LSS ex-
tracts from WT, but not from NE knockout mouse peritoneal 
neutrophils, decondensed nuclei in vitro (Fig. 6 C). Despite 
our efforts, peritoneal mouse neutrophils responded poorly to 
stimulation ex vivo, reflecting our current inability to potently 
stimulate  NET  formation  in  these  isolated  cells  (Fig.  S5).   
Collectively, these results indicate that NE is the major pro-
tease driving nuclear decondensation during NET formation 
in vivo.
Discussion
According to our model, ROS production leads to the release 
of NE and subsequently MPO from azurophilic granules. NE 
translocates first to the nucleus, where it digests nucleosomal 
histones  and  promotes  extensive  chromatin  decondensation 
(Fig. 7). In contrast to this crude approach, posttranslational 
histone modifications are well-suited for fine and reversible 
spatiotemporal control. Our data also imply that the late bind-
ing of MPO to chromatin enhances decondensation indepen-
dent of its enzymatic activity. This synergy may constitute an 
important trigger for timely cell rupture and NET release. MPO 
may drive chromatin decondensation by promoting a relaxed 
chromatin state, but the details of the molecular mechanism re-
main to be addressed.
In addition to histone degradation, posttranslational modifi-
cations may also play a role during NET formation. We observed 
of NEi (Fig. 4 C). By monitoring the release of NE during stim-
ulation, we confirmed that significant levels of the NE remained 
intracellular during the first 2 h (Fig. 4 D).
NE translocates to the nucleus during  
NET formation
During NET formation, NE localized to the nucleus 60 min after 
stimulation, accompanied by reduced granular staining (Fig. 5 A, ii).   
In contrast, only low levels of PR3 were detected in the hetero-
chromatin areas of the nucleus, arguing for a selective trans-
location of NE. After 120 min of stimulation, NE, but not PR3, 
was found predominantly in the decondensing nucleus in a diffuse 
gradient-like pattern (Fig. 5 A, iii). Interestingly, when neutro-
phils were treated with NEi, NE remained granular (Fig. 5 A, v), 
which suggests that NE activity is required for NE translocation. 
Because NE bound efficiently to isolated nuclei in the presence of 
NEi, NE activity may be required for granular release (Fig. 2 E).
In contrast to NE, MPO remained granular until the 
later stages of NET formation (Fig. 5 B, i), where it colocal-
ized with NE and DNA in neutrophils undergoing NET release   
(Fig. 5 B, ii). Consistently, NE translocated faster than MPO   
in vitro (Fig. 1 F). Furthermore, the translocation of MPO was 
also blocked by NEi (Fig. 5 C).
We detected high levels of NE in the nuclei of neutrophils 
undergoing NET formation by immunoblot analysis, whereas 
NE activity was selectively decreased in the granules compared 
with MPO (Fig. 5 D). We did not detect NE activity in the nu-
clear fraction of either sample, as expected from the inhibitory 
effect of DNA (Fig. S3 A; Belorgey and Bieth, 1995). More-
over, CD63, a transmembrane protein found in azurophilic 
granule membranes, was not perinuclear at any point during 
NET formation. This indicates that the granules do not fuse 
with the nuclear membrane. Instead, NE is released from the 
granules and then translocates to the nucleus, a hypothesis that 
remains to be confirmed (Fig. S4).
Although it is conceivable that in isolated neutrophils, NE 
is first externalized and then binds to the nucleus of necrotic neu-
trophils, our observations argue against this possibility. The trans-
location of NE to the nucleus is selective and occurs within 1 h after 
stimulation (Fig. 5 A, iii), whereas neutrophil death occurs only 
after 3 h of stimulation with PMA (Fig. 4 B). Moreover, NE is not 
significantly externalized during that time (Fig. 4 D). Finally, cell 
death is primarily caused by NET formation, as neutrophil death 
is strikingly reduced when NE activity is inhibited (Fig. 3 B). 
However, such a mechanism may represent an alternative route to 
NET formation during an infection where externalized NE may 
process nuclei derived from necrotic bystander cells.
NE is required for NET formation in vivo
We examined NET formation in the lungs of wild type (WT) 
and NE knockout mice infected intranasally with a sublethal 
during activation. Lysates from naive and activated neutrophils were prepared after 60 min of incubation and separated into cytoplasmic (HSS) and 
granule (HSP) fractions. The enzymatic activity (initial rate of change in absorbance) was normalized to the total amount of MPO (MPOt), which remains 
unchanged, and plotted as the fraction of NE activity over total MPO activity (open bars). The distribution of MPO activity in each sample over total MPO 
activity is also shown (shaded bars). Samples were also resolved by SDS-PAGE and analyzed by immunoblotting against MPO, NE, and histone H2B.
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Figure 6.  NE knockout mice fail to form NETs. (A) Representative fluorescence images of the lungs of WT (i) and NE knockout (ii) mice infected with   
K. pneumoniae, and stained with antibodies against MPO (green) and against a DNA/histone complex (red). The lungs of WT mice (i) contain decon-
densed web-like chromatin structures that stain for MPO (arrow). In contrast, in the lungs of NE knockout mice, all neutrophils appear naive, with condensed 
nuclei and granular MPO staining (asterisks). Bar, 20 µm. (B) NETs (arrows) trapping bacteria are detected in scanning electron micrographs of WT mouse 
lungs (i and ii) infected with K. pneumoniae. The lungs of NE knockout animals are devoid of NETs (iii and iv). Bars: (i and iii) 100 nm; (ii and iv) 1 µm. 
(C) Lysates from NE knockout mouse peritoneal neutrophils lack nuclear decondensation activity in vitro. Cell-free nuclear decondensation assays of mouse 
peritoneal nuclei treated for 2 h with LSS extracts from peritoneal neutrophils derived from WT and NE knockout mice are shown. ***, P < 0.0001.687 Neutrophil elastase in extracellular trap formation • Papayannopoulos et al.
resulting increase in membrane permeability is thought to apply 
to ions and not larger molecules (Lemasters et al., 2002). Alter-
natively, the membrane of some granules may be more exten-
sively disrupted through an unidentified mechanism. In support   
of  a  membrane  breakdown  mechanism,  we  have  previously 
reported that the nuclear envelope and granular membranes dis-
appear during NET formation (Fuchs et al., 2007). Understanding 
how NE and MPO translocate from the granules to the nucleus 
is a complex question that awaits further investigation.
This release mechanism may represent a new concept in 
cell biology associated with the oxidative burst that may not be 
restricted to neutrophils. However, the release of NE is reminis-
cent of the lysosomal membrane permeabilization observed 
during cell death (Boya and Kroemer, 2008). As in the case 
of NET formation, lysosomal lysis implicates ROS and requires 
protease activation. In such a case, neutrophils may have adapted 
the same concept for NET formation.
An important role of NETs may be the sequestration of 
the neutrophil’s toxic antimicrobials to minimize tissue dam-
age (Henson and Johnston, 1987; Weiss, 1989; Xu et al., 2009).   
Using antimicrobials as key factors in NET formation ensures 
that these toxic proteins are sequestered by chromatin. A two-step 
mechanism provides the necessary time for these proteins to bind 
to chromatin before neutrophil rupture. Allowing NE to operate 
early protects other NET proteins from being degraded by NE 
while it is still active inside the nucleus. Moreover, the inhibitory 
effect of DNA on NE activity may slow down the degradation 
of DNA-bound proteins, preserving their antimicrobial capacity. 
Interestingly, although histone degradation fragments are more 
potent antimicrobials than the intact proteins (Kawasaki and 
Iwamuro, 2008), the degradation of histones reduces cytotoxicity 
against the host during sepsis (Xu et al., 2009).
The requirement of neutrophil-specific factors explains 
why thus far extracellular trap formation is restricted to granu-
locytes, which also produce the highest levels of ROS (Segal, 
2005). Mast cells express mast cell protease II, and eosino-
phil elastase is found in eosinophils (Woodbury et al., 1978;   
Lungarella et al., 1992). However, eosinophils may not require 
several shifts in the mobility of histone H3 that may represent 
such modifications (Fig. 4 A). In particular, histone citrullina-
tion has been observed in chromatin released by neutrophil- 
like human leukemia 60 (HL-60) cells and primary neutrophils 
(Neeli et al., 2008; Wang et al., 2009). The peptidylarginine 
deiminase 4 (PAD4) inhibitor Cl
-amidine was tested against   
HL-60 cells, where it was shown to block hypercitrullination 
and limit chromatin release in response to IL-8 and Shigella 
flexneri (Wang et al., 2009). However, Wang et al. (2009) did not 
test Cl
-amidine in primary neutrophils but showed that over-
expression of active PAD4 is sufficient to induce NET formation   
in HL-60 cells, although the overall NET yield is low in these 
cells. Citrullination may account for some of the NE-independent 
shifts observed in histone H3 during NET formation only in con-
junction with additional modifications because deimination has 
been reported to increase the mobility of these proteins (Wang 
et al., 2004). Alternatively, in the absence of NEi, NE may 
first cleave histone H3 to a lower molecular weight moiety. 
Over time, the cleaved histone H3 may accumulate additional   
modifications, which may account for the apparent higher 
molecular weight shifts. Whether PAD4 is required for NET 
formation remains to be tested in primary neutrophils and in vivo. 
Nevertheless, it is interesting to speculate that posttranslational 
histone modifications may regulate NET formation by modulat-
ing the ability of NE to cleave histones.
The intracellular release of NE underlies the existence of 
an as yet unknown mechanism that allows granular proteins to 
be selectively released into the cytoplasm. ROS could promote 
the release of NE directly by disrupting the association of NE 
with the proteoglycan matrix that is thought to down-regulate 
protease activity in resting cells (Serafin et al., 1986; Kolset and 
Gallagher, 1990; Reeves et al., 2002). Consistently, we find that 
NE activity is required for NE translocation. NE and MPO may 
be differentially released from the matrix because of differences 
in net surface charge and size. Alternatively, the release of these 
proteins may not involve such interactions because Niemann 
et al. (2004) did not detect serglycin in mature circulating neu-
trophils. In addition, ROS may drive lipid peroxidation, but the 
Figure 7.  Model of NET formation. In resting neutrophils, NE and MPO are stored in the azurophilic granules. Upon activation and ROS production, NE 
escapes the granules and translocates to the nucleus. In the nucleus, NE cleaves histones and promotes chromatin decondensation. MPO binds to chromatin 
in the late stages of the process. MPO binding promotes further decondensation. NE and MPO cooperatively enhance chromatin decondensation, leading 
to cell rupture and NET release.JCB • VOLUME 191 • NUMBER 3 • 2010   688
humidified chamber at 37°C for 120 min (unless otherwise specified).   
Sytox-labeled nuclei were analyzed by fluorescence microscopy.
Cell-free nuclear decondensation assay over filters
100-µl reactions containing 10
5 nuclei and 90 µl LSS extract, buffer, or 
granules were incubated for 2 h at 37°C. The reactions were then centri-
fuged through Ultrafree-MC Amicon polyvinylidene fluoride (PVDF) filters 
with a 0.65-µm pore size (Millipore) to separate the soluble flowthrough, 
containing the cytoplasm and the granules, from the nuclear material and 
bound proteins, which are retained by the filter. The filters were washed 
three times in cell lysis buffer, and the nuclear material was eluted with   
120 µl of 1× SDS sample buffer. 20 µl of 6× SDS sample buffer was added 
to the 100 µl FT. Before the initiation of the reactions, a 3-µl aliquot was 
removed and placed on diagnostic slides, and 0.3 µl of 10× Sytox was 
added to measure nuclear decondensation by microscopy at the indicated 
time points.
Quantitation of chromatin decondensation and NET formation
Sytox images of unfixed neutrophils or nuclei were analyzed using ImageJ 
image processing software. The area of Sytox signal for 300–500 cells per 
sample was individually measured. For quantitation of nuclear deconden-
sation, we plotted the mean DNA area derived from each nucleus (circles) 
and the standard deviation of the values (bars) denoting the range of areas 
for each condition. For NET formation, the distribution of the number of 
cells across the range of nuclear area was obtained using the frequency 
function in Excel (Microsoft). The data were converted to a percentage of 
Sytox-positive cells by dividing the Sytox-positive counts by the total num-
ber of cells as determined from corresponding phase-contrast images, and 
plotted as the percentage of all cells that were positive for Sytox for each 
DNA area range.
NET formation
We seeded 5 × 10
4 neutrophils per well in 24-well plates, in HBSS(+) 
(including calcium and magnesium), supplemented with 10% FCS. Cells 
were allowed to settle onto uncoated plates for 1 h before stimulation with 
100 nM PMA. Sytox green (1:15,000) was added and NETs were visu-
alized by fluorescence microscopy. Wherever indicated, cells were pre-
treated with 5 µM NEi (GW311616A; Sigma-Aldrich) or CGi (219372; 
EMD) for 1 h before stimulation. Stimulation with C. albicans was per-
formed in HBSS(+) medium supplemented with 10% human serum at an 
MOI of 10. C. albicans were grown overnight at 30°C in YPD media and 
subcultured to reach an exponential phase. Sytox images were taken 3 h   
after infection.
Histone degradation during NET formation
At each time point, the medium was removed and 5 × 10
5 neutrophils were 
resuspended in 300 µl of 1× SDS loading buffer. Samples were resolved   
by SDS-PAGE electrophoresis, transferred to PVDF, blocked in 5% BSA,   
and labeled with primary antibodies and secondary horseradish peroxidase–
conjugated antibodies (see Antibodies for Western immunoblotting).
Extracellular NE was measured by removing half the volume of 
media. NE levels were quantitated by ELISA. MNase (2 U/ml) was pres-
ent throughout the time course to solubilize any extracellular NE bound 
to DNA.
Antibodies for Western immunoblotting
1:1,000 rabbit anti-H2A (2578, recognizes the C terminus; Cell Signaling 
Technology), 1:5,000 anti-H2B (07-371, recognizes aa 118–126; Milli-
pore), 1:10,000 anti-H3 (07-690, recognizes the C terminus; Millipore), 
1:5,000 anti-H4 (04-858, epitope mapped to aa 25–28; Millipore), and 
the pan-histone antibody MAB052 (1:500; Millipore) for analysis of H1. 
Rabbit anti-NE (ab21595; Abcam) was used at 1:200, or rabbit anti-NE 
(EMD) was used at 1:500. 1:10,000 anti-MPO (A0398; Dako), 1:500 
anti-gelatinase (Dako), and 1:500 anti-lactoferrin (Sigma-Aldrich) were also 
used. Secondary antibodies conjugated to horseradish peroxidase (Jackson 
ImmunoResearch Laboratories, Inc.) were used at a 1:20,000 dilution.
Immunostaining and microscopy
Cells were fixed in 4% paraformaldehyde, permeabilized with 0.2% Triton 
X-100, blocked with 3% BSA, and stained with the following primary anti-
bodies: 1:500 mouse anti-NE (in house), 1:200 rabbit anti-NE (EMD), 
1:200 rabbit anti-MPO (Dako), 1:200 EPC rabbit anti-PR3, 1:200 mouse 
anti-CD63 (CBL 553; Millipore),and DRAQ5 (Biostatus Limited). Second-
ary antibodies conjugated with Cy2 and Cy3 (Invitrogen) were used. Con-
focal images were obtained using a confocal fluorescence microscope 
(TCS-SP; Leica) and a Fluotar 100× objective lens; images were captured 
proteases, as they release their mitochondrial DNA, which lacks 
histones (Yousefi et al., 2008). Moreover, the contribution of 
other cell-specific peroxidases (Henderson and Kaliner, 1979; 
Ten et al., 1989) in ET formation may be closely associated with 
their ability to interact with DNA.
The immunodeficiency of NE and MPO knockout mice 
may be due in part to a defect in NET formation. Our findings 
may help explain the nonredundancy of NE with other related 
serine proteases. Mutations in NE are associated with neutro-
penias that are treatable with granulocyte colony-stimulating 
factor (G-CSF; Ancliff et al., 2001; Aprikyan and Dale, 2001). 
Patients treated with G-CSF display neutrophils devoid of 
granular proteins (Horwitz et al., 2007). In spite of having near 
normal neutrophil counts, death from sepsis still poses a high 
risk in patients treated with G-CSF. With G-CSF treatment, 
mortality caused by sepsis has decreased from 6% to 0.9% per 
year (Rosenberg et al., 2006). The remaining risk in neutropenic 
patients with mutations in NE may be due in part to a defect in 
NET formation. Because the molecules involved in NET for-
mation play important roles in other neutrophil antimicrobial 
mechanisms, it is difficult to dissect the contribution of NETs 
in immune defense. Notably, microbes have evolved virulence 
factors to degrade NETs (Beiter et al., 2006; Buchanan et al., 
2006; Walker et al., 2007; Lauth et al., 2009). Therefore, it 
could be informative to document the types of microbes that 
infect patients with different immunodeficiencies, and associate 
them to their susceptibility to NETs.
The advances presented here uncover a novel mechanism 
for NET formation that may help to better understand and treat 
human immunodeficiency, sepsis, and autoimmune disease.
Materials and methods
Cell isolation and NET formation
Blood was drawn from healthy volunteers, and neutrophils were isolated 
over a Histopaque 1119 bed and a discontinuous Percoll gradient as de-
scribed previously (Fuchs et al., 2007). Cells were stored in HBSS() (with-
out calcium or magnesium) before experiments. PBMCs were isolated from 
the same preparation.
Preparation of extracts, nuclei, and granular fractionation
Extracts were prepared from 5 × 10
7 neutrophils/ml, which were lysed 
by douncing in 20 mM Hepes, pH 7.4, 100 mM KCl, 100 mM sucrose, 
100 mM NaCl, 3 mM MgCl2, 1 mM EGTA, protease inhibitor cocktail 
pellets (Roche), and 0.1 mM PMSF. LSS was prepared by removal of 
nuclei by centrifugation at 300 g for 10 min. HSS was prepared by 
centrifugation of LSS at 100,000 g for 1 h. For granule preparations, 
cells  were  lysed  by  nitrogen  cavitation  followed  by  light  douncing. 
The granule fractionation was performed by centrifugation (37,000 g,   
20 min) of LSS prepared in 20 mM Hepes, pH 7.4, 100 mM KCl, 100 mM 
sucrose, 3 mM NaCl, 3 mM MgCl2, and 1 mM EGTA, over a discon-
tinuous (1.050, 1.090, and 1.120 g/ml) Percoll gradient as described 
previously (Kjeldsen et al., 1994; Lominadze et al., 2005). Gradient 
fractions were isolated and centrifuged at 100,000 g for 1 h to remove 
the residual Percoll. Granule fractions were resuspended into the original 
volume of LSS. HL-60 lysates and nuclei were prepared from HL-60 cells 
differentiated with 5 µM retinoic acid for 96 h. Intact nuclei were isolated 
as described by Celis (1998).
Cell-free nuclear decondensation assay
Reactions of 10 µl of LSS extract at 10 mg/ml total protein (derived from 
3–5 × 10
7 neutrophils/ml), the equivalent amount of HSP, or isolated gran-
ules, were mixed with 10
4 nuclei and Sytox. Before incubation, 3-µl ali-
quots were transferred onto 12-well, 5-mm diagnostic slides (Menzel-Glaser) 
and covered with 20 × 50 mm coverslips. Reactions were performed in a 689 Neutrophil elastase in extracellular trap formation • Papayannopoulos et al.
of 1 mM H2O2. Where indicated (Fig. S3), 0.3 mg/ml of plasmid DNA or 
2 × 10
4/ml nuclei derived from RA-differentiated HL-60 cells were added 
to protease activity reactions. NE ELISA was performed using the Human 
Elastase ELISA test kit (Hycult biotechnology).
Statistical analysis
Raw measurements were analyzed in Graph Pad Prism 5 software using 
Kruskal-Wallis analysis of variance and Dunn’s multiple comparisons test 
for pairwise comparisons (***, P < 0.0001). All experiments have been 
repeated at least three times unless indicated.
Online supplemental material
Fig. S1 shows the specificity of the NE inhibitor. Fig. S2 shows that histone 
degradation  mediates  NE-mediated  nuclear  decondensation.  Fig.  S3 
shows that DNA and nuclear binding inhibits NE activity. Fig. S4 shows 
that azurophilic granules do not fuse with the nuclear membrane during 
NET formation. Fig. S5 shows that mouse peritoneal neutrophils do not 
form NETs in response to PMA. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.201006052/DC1.
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